Thrivent Financial for Lutherans
PJP icon

Thrivent Financial for Lutherans’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Thrivent Financial for Lutherans’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-60
Closed -$4K – 2222
2017
Q3 		$4K Buy
+60
New +$3.79K ﹤0.01% 2228

Other funds holding PJP

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Thrivent Financial for Lutherans's PJP Position: Q4 2017 in Review

Thrivent Financial for Lutherans sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2017, closing a stake of 60 shares — an estimated $4K sold.

Thrivent Financial for Lutherans first reported a position in PJP in Q3 2017 and held it in 1 quarter. The position peaked at $4K in Q3 2017. 92 funds tracked by Wall St. Rank hold PJP as of Q4 2017.

  • Thrivent Financial for Lutherans reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2017 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 60 Invesco Pharmaceuticals ETF shares in Q4 2017, an estimated $4K.
  • Thrivent Financial for Lutherans first reported a position in Invesco Pharmaceuticals ETF in Q3 2017 and held it in 1 quarter.
  • Thrivent Financial for Lutherans's Invesco Pharmaceuticals ETF position peaked at $4K in Q3 2017.
  • 92 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2017.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2017, filed 14 Feb 2018.